Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by University of Washington
Sponsor:
Collaborators:
Prostate Cancer Foundation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT01703065
First received: October 5, 2012
Last updated: February 21, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 1, 2019
  Estimated Primary Completion Date: February 18, 2019 (Final data collection date for primary outcome measure)